{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T09:16:40Z","timestamp":1777713400663,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.intimp.2014.04.022","type":"journal-article","created":{"date-parts":[[2014,5,9]],"date-time":"2014-05-09T20:00:24Z","timestamp":1399665624000},"page":"156-162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Adenovirus expressing IFN-\u03bb1 (IL-29) attenuates allergic airway inflammation and airway hyperreactivity in experimental asthma"],"prefix":"10.1016","volume":"21","author":[{"given":"Yan","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiaoyan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianli","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingcai","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2014.04.022_bb0005","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1146\/annurev.physiol.010908.163200","article-title":"Immunobiology of asthma","volume":"71","author":"Hamid","year":"2009","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.intimp.2014.04.022_bb0010","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jaci.2009.01.041","article-title":"Advances in mechanisms of asthma, allergy, and immunology in 2008","volume":"123","author":"Boyce","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.intimp.2014.04.022_bb0015","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.tips.2010.04.009","article-title":"New therapies for asthma: is there any progress?","volume":"31","author":"Barnes","year":"2010","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.intimp.2014.04.022_bb0020","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/MCP.0b013e32831da867","article-title":"Novel targets of therapy in asthma","volume":"15","author":"Holgate","year":"2009","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.intimp.2014.04.022_bb0025","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ni875","article-title":"IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex","volume":"4","author":"Kotenko","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.intimp.2014.04.022_bb0030","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/ni873","article-title":"IL-28, IL-29 and their class II cytokine receptor IL-28R","volume":"4","author":"Sheppard","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.intimp.2014.04.022_bb0035","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1189\/jlb.1208761","article-title":"Interferon-lambdas: the modulators of antivirus, antitumor, and immune responses","volume":"86","author":"Li","year":"2009","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.intimp.2014.04.022_bb0040","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/sj.gene.6364382","article-title":"Human interferon lambda-1 (IFN-lambda1\/IL-29) modulates the Th1\/Th2 response","volume":"8","author":"Jordan","year":"2007","journal-title":"Genes Immun"},{"key":"10.1016\/j.intimp.2014.04.022_bb0045","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1365-2567.2008.02862.x","article-title":"Interferon-lambda1 (interleukin-29) preferentially down-regulates interleukin-13 over other T helper type 2 cytokine responses in vitro","volume":"125","author":"Srinivas","year":"2008","journal-title":"Immunology"},{"key":"10.1016\/j.intimp.2014.04.022_bb0050","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nm1462","article-title":"Role of deficient type III interferon-lambda production in asthma exacerbations","volume":"12","author":"Contoli","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.intimp.2014.04.022_bb0055","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1111\/j.1365-2222.2008.03045.x","article-title":"Type III IFN-lambda mRNA expression in sputum of adult and school-aged asthmatics","volume":"38","author":"Bullens","year":"2008","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.intimp.2014.04.022_bb0060","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1164\/rccm.201108-1462OC","article-title":"A mechanistic role for type III IFN-lambda1 in asthma exacerbations mediated by human rhinoviruses","volume":"185","author":"Miller","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.intimp.2014.04.022_bb0065","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/emmm.201100142","article-title":"IL-28A (IFN-lambda2) modulates lung DC function to promote Th1 immune skewing and suppress allergic airway disease","volume":"3","author":"Koltsida","year":"2011","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.intimp.2014.04.022_bb0070","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.bbrc.2009.06.008","article-title":"Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma","volume":"386","author":"Liu","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.intimp.2014.04.022_bb0075","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jaci.2006.04.021","article-title":"Adiponectin attenuates allergen-induced airway inflammation and hyperresponsiveness in mice","volume":"118","author":"Shore","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.intimp.2014.04.022_bb0080","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1038\/sj.gt.3302798","article-title":"Adenovirus expressing interleukin-1 receptor antagonist alleviates allergic airway inflammation in a murine model of asthma","volume":"13","author":"Wang","year":"2006","journal-title":"Gene Ther"},{"key":"10.1016\/j.intimp.2014.04.022_bb0085","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1745-7254.2006.00292.x","article-title":"Liposome-mediated IL-28 and IL-29 expression in A549 cells and anti-viral effect of IL-28 and IL-29 on WISH cells","volume":"27","author":"Li","year":"2006","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.intimp.2014.04.022_bb0090","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1099\/vir.0.80904-0","article-title":"Murine interferon lambdas (type III interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model","volume":"86","author":"Bartlett","year":"2005","journal-title":"J Gen Virol"},{"key":"10.1016\/j.intimp.2014.04.022_bb0095","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.2174\/092986709788803196","article-title":"The mechanism of mucus production in bronchial asthma","volume":"16","author":"Izuhara","year":"2009","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.intimp.2014.04.022_bb0100","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.4049\/jimmunol.0902185","article-title":"Importance of cytokines in murine allergic airway disease and human asthma","volume":"184","author":"Finkelman","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2014.04.022_bb0105","doi-asserted-by":"crossref","first-page":"6233","DOI":"10.4049\/jimmunol.162.10.6233","article-title":"IL-4 induces mucin gene expression and goblet cell metaplasia in vitro and in vivo","volume":"162","author":"Dabbagh","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2014.04.022_bb0110","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.jaci.2009.11.048","article-title":"A review of treatment with mepolizumab, an anti-IL-5 mAb, in hypereosinophilic syndromes and asthma","volume":"125","author":"Busse","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.intimp.2014.04.022_bb0115","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev.immunol.21.120601.141142","article-title":"IL-13 effector functions","volume":"21","author":"Wynn","year":"2003","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.intimp.2014.04.022_bb0120","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000315936","article-title":"T-cell response to allergens","volume":"95","author":"Ozdemir","year":"2010","journal-title":"Chem Immunol Allergy"},{"key":"10.1016\/j.intimp.2014.04.022_bb0125","doi-asserted-by":"crossref","first-page":"29882","DOI":"10.1074\/jbc.M804742200","article-title":"Attenuation of IgE affinity for FcepsilonRI radically reduces the allergic response in vitro and in vivo","volume":"283","author":"Hunt","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.intimp.2014.04.022_bb0130","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jaci.2005.09.004","article-title":"T regulatory cells in allergy: novel concepts in the pathogenesis, prevention, and treatment of allergic diseases","volume":"116","author":"Akdis","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.intimp.2014.04.022_bb0135","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jaci.2008.05.048","article-title":"CD4+CD25+ regulatory T cells reverse established allergic airway inflammation and prevent airway remodeling","volume":"122","author":"Kearley","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.intimp.2014.04.022_bb0140","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1182\/blood-2005-10-4129","article-title":"Interferon-lambda-treated dendritic cells specifically induce proliferation of FOXP3-expressing suppressor T cells","volume":"107","author":"Mennechet","year":"2006","journal-title":"Blood"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576914001581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576914001581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T01:00:13Z","timestamp":1689210013000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576914001581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S1567576914001581"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2014.04.022","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adenovirus expressing IFN-\u03bb1 (IL-29) attenuates allergic airway inflammation and airway hyperreactivity in experimental asthma","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2014.04.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}